Introduction
============

Rhabdomyolysis-induced pigment nephropathy is common, accounting for about 7--10% of all cases of acute kidney injury (AKI) \[[@sfx121-B1]\]. Etiology of rhabdomyolysis and pigment nephropathy differ in Western and tropical countries. There is a paucity of data in the Indian literature; hence, we intend to study the etiology, clinical manifestation, laboratory profile and outcome in patients with biopsy-proven pigment-induced nephropathy.

Materials and methods
=====================

We performed a retrospective observational study in patients admitted to the Institute of Nephrology, Madras Medical College, Chennai with various causes of AKI and renal biopsy showing pigment nephropathy during January 2011 to December 2016. Those patients with lost follow-up of at least 3 months and underlying known renal disease were excluded. Renal biopsy was done in patients who had persistent oliguria for \>7 days and renal failure for \>14 days despite supportive treatment. Perls staining for iron was done in all patients and immunostaining for myoglobin in selected patients. Detailed history including history of recent trauma, exertion, seizures, infections and intake of alcohol/medications, demographic data and clinical findings were noted.

Laboratory investigations included urine analysis, spot urine protein:creatinine ratio, urine myoglobin, plasma free hemoglobin, reticulocyte count blood urea, serum creatinine, sodium, potassium, calcium, prothrombin time, serum creatine phosphokinase (CPK), Lactate dehydrogenase (LDH) and liver function tests, treatment details and outcome were recorded.

All the renal biopsies were subjected to light microscopy with various stains including hemotoxylin and eosin, Periodic acid--Schiff, trichrome, Periodic Schiff-methanamine and Perls Prussian blue stain. Perls stain for iron confirms hemosiderin seen in the tubular epithelial cell cytoplasm. In the presence of intratubular pigment casts with a globular/ropy appearance, myoglobin immunohistochemistry (IHC) was done whenever possible. Hemoglobin IHC was not done due to unavailability. The etiology of rhabdomyolysis and hemolysis was ascertained by clinical history and laboratory findings.

All the patients received supportive treatment and forced alkaline diuresis was given when presenting without volume overload or oliguria. Indications of hemodialysis (HD) were oligoanuria, hyperkalemia (\>5.5 mEq/L), metabolic acidosis and acute pulmonary edema.

AKI was defined as per Kidney Disease Improving Global Outcomes 2012 guidelines as increase in serum creatinine by ≥0.3 mg/dL within 48 h or increase in serum creatinine to 1.5 times from baseline that is known or presumed to have occurred within the prior 7 days or urine volume \<0.5 mL/kg/h for 6 h. Complete recovery of kidney function was defined as a decrease in the serum creatinine level to within a normal range. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate \<60 mL/min/1.73 m^2^ at 3 months after the onset of AKI. The presence of rhabdomyolysis was diagnosed by clinical history and elevated serum CPK \>390 IU/L (three times the normal) and hemolysis by elevated LDH (\>420 IU/L), anemia (Hb\<10 mg/dL) and elevated bilirubin. Data are expressed as mean (± standard deviation), median (range), numbers or percentages. The differences in variables between patients with rhabdomyolysis or hemolysis were assessed using the chi-square test. All calculations were performed using the SPSS software package (v15.0, SPSS Inc., Chicago, IL, USA). P \< 0.05 was taken as statistical significance.

Results
=======

The total number of AKI cases over 6 years was 3300, out of which 155 (4.7%) had laboratory evidence of rhabdomyolysis and 98 patients (2.9%) had evidence of hemolysis. A total of 46 patients with biopsy-proven pigment cast \[26 patients (56%) with rhabdomyolysis and 20 patients (44%)\] were included with mean follow-up of 14 ± 5.5 months. Those patients with clinical and laboratory evidence of rhabdomyolysis or hemolysis but no demonstrable pigment cast in renal biopsy were excluded from the study. Demographic and clinical data are given in Table [1](#sfx121-T1){ref-type="table"}. Mean serum CPK was 2319 ± 690 IU/L and mean serum LDH was 2128 ± 890 IU/L. Out of 26 patients with rhabdomyolysis, 8 patients had serum CPK \<1500 IU/L and 18 patients had \>1500 IU/L. Only five patients had severe rhabdomyolysis, as defined by serum CPK \>5000 IU/L, hypoalbuminemia, hyperkalemia and hypocalcemia. Approximately 20 patients presented with hemolysis, of which the most common was rifampicin induced (7 patients), followed by sepsis (5), malaria (3), mismatched blood transfusion/transfusion reaction (3) and paroxysmal nocturnal hemoglobinuria (PNH) (2). In rifampicin-induced hemolysis, the mean duration of anti-tuberculosis treatment was 2 weeks; all the patients were on intermittent therapy. The etiology of AKI due to rhabdomyolysis and hemolysis in our study in comparison with the literature are given in Table [2](#sfx121-T2){ref-type="table"}. In our study, 26 out 155 rhabdomyolysis patients and 20 out of 98 hemolysis patients had pigment casts (P = 0.54). All renal biopsies revealed acute tubular injury in dilated tubules, swollen tubular epithelial cells with cytoplasmic vacuoles, sloughed off epithelial cells forming granular debris, edematous interstitium and pigment casts (Figure [1](#sfx121-F1){ref-type="fig"}) in the tubules. None of the patients had significant glomerulosclerosis, interstitial fibrosis or tubular atrophy. Out of 26 patients with evidence of rhabdomyolysis, myoglobin immunostaining (Figure [2](#sfx121-F2){ref-type="fig"}) was done in 18 patients and was found to be positive and all 20 biopsies with hemolysis revealed Perls stain positivity in cytoplasm. In all, two patients had acute interstitial nephritis and two had immunoglobulin A deposits in addition to pigment nephropathy. There was no significant difference noted in the morphology of pigment casts due to rhabdomyolysis or hemolyis except that Perls stain positivity in cytoplasm was seen in all 20 patients with hemolysis but only in 1 patient with rhabdomyolysis. Some minimal lymphocytic interstitial infiltrates were noted in 8 out of 26 rhabdomyolysis patients and in 6 out of 20 hemolysis patients. All except one patient (97.8%) required HD and mean number of HD sessions was 9 ± 2. A total of three patients (6.5%) died with sepsis/disseminated intravascular coagulation (DIC), all had AKI due to hemolysis etiology. Statistical analysis of variables between AKI due to rhabdomyolysis and hemolysis is given in Table [3](#sfx121-T3){ref-type="table"}. There was no difference between AKI due to rhabdomyolysis and hemolysis except for high CPK in patients with rhabdomyolysis and LDH level in patients with hemolysis. At mean follow-up, five patients (12%) had progressed to CKD. Out of these, two were due to severe rhabdomyolysis and three due to hemolysis. Table 1.Demographic and clinical data in patientsVariables*N* = 46Males30 (65%)Mean age (years)40.15 ± 12.3Oliguria at presentation37 (80.4%)Mean creatinine at presentation (mg/dL)7.5 ± 2.2Mean peak serum creatinine (mg/dL)12.1 ± 4.3Mean serum CPK (IU/L)2319 ± 690Mean serum LDH (IU/L)2128 ± 890Mean serum potassium (mEq/L)4.9 ± 2.3Mean serum calcium (mg/dL)8.04 ± 4.5Mean serum phosphorus (mg/dL)4.95 ± 2.3Mean serum uric acid (mg/dL)5.95 ± 3.2Mean number of HD sessions9 ± 2Table 2.Etiology of rhabdomyolysis and hemolysis causing AKICommon causesCauses in our study (*n*)Rhabdomyolysis*N* = 26 Extreme physical exercise/seizures Extreme temperatures Trauma/crush syndrome Vascular ischemia Drug induced Infections/sepsis Toxins Endocrine disorders Metabolic/electrolyte disordersSnake envenomation (10)Seizures (7)Strenuous exercise (5)Wasp sting (2)Rifampicin induced (2)Hemolysis*N*= 20 ABO-incompatible blood transfusions Glucose-6-phosphate dehydrogenase (G6PD) deficiency Poisoning Snake and insect bites Drug reactions PNH MalariaRifampicin induced (7)Sepsis/DIC (5)Malaria (3)Mismatched blood transfusion/transfusion reaction (3)PNH (2)Table 3.Variables between AKI due to rhabdomyolysis and hemolysisVariablesRhabdomyolysisHemolysisP-valueNumber2620Mean age (years)41.139.20.91Mean CPK (IU/L)358110570.002Mean LDH (IU/L)129429620.0001Mean potassium (mEq/L)5.24.610.88Mean calcium (mg/dL)8.068.030.97Mean phosphorus (mg/dL)4.65.30.45Mean uric acid (mg/dL)4.77.20.20Mean number of HD sessions9.38.60.71Death030.05
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Discussion
==========

The causes of pigment-induced nephropathy are rhabdomyolysis, intravascular hemolysis and bile pigment nephropathy due to cholestasis. Rhabdomyolysis refers to disintegration of striated muscle, resulting in the release of muscular cell constituents into the circulation \[[@sfx121-B2]\]. The mechanisms of renal toxicity by myoglobin, a 17.8-kDa protein, are renal vasoconstriction, formation of intratubular casts and the direct toxicity of myoglobin to kidney tubular cells \[[@sfx121-B3], [@sfx121-B4]\]. Myoglobin is filtered by the glomeruli, gets concentrated along the renal tubules and precipitates with the Tamm--Horsfall protein, a process favored by acidic urine. It appears in the urine only when the renal threshold of 0.5--1.5 mg/dL of myoglobin is exceeded. Tubule obstruction occurs usually at the distal tubules, and direct tubule toxicity occurs in the proximal tubules. Serum CPK is the most sensitive enzyme marker of muscle injury. Though serum myoglobin levels peak before serum CPK, it has a rapid and unpredictable metabolism. The measurement of serum myoglobin has a low sensitivity for the diagnosis of rhabdomyolysis \[[@sfx121-B5]\]. There is no defined threshold value of serum CPK above which the risk of AKI is markedly increased, although values \>5000 U/L have been reported to increase the risk of AKI, but only five patients in our study had such high values \[[@sfx121-B6], [@sfx121-B7]\]. Rhabdomyolysis-induced AKI was first described by Meyer-Betz in 1911 \[[@sfx121-B8]\]. Approximately 10--50% of patients with rhabdomyolysis develop AKI, and it contributes to 5--25% of all cases of AKI \[[@sfx121-B9], [@sfx121-B10]\]. In our study, rhabdomyolysis contributed to ∼4.7% of total AKI.

In a retrospective study involving 126 patients with severe rhabdomyolysis with a 9-year follow-up, the incidence of AKI was 58%. The causes of rhabdomyolysis \[[@sfx121-B11]\] include immobilization due to illicit drugs abuse (27.8%), infectious disease (19.8%), trauma (7.1%), stroke (4.8%), surgery (3.2%) and other (30.2%), whereas it was due to snake envenomation (38%), seizures (30%), strenuous exercise (19%), wasp sting (6.5%) and rifampicin induced (6.5%) in our study. Death was significantly higher among patients with AKI, compared with patients without AKI (19.2% versus 3.6%). The risk factors for AKI include peak CPK, hypoalbuminemia, metabolic acidosis and decreased prothrombin time. The mortality rate varied from 3.5% to 22% \[[@sfx121-B3], [@sfx121-B12], [@sfx121-B13]\]. None of our patients with rhabdomyolysis-induced AKI died. Hyperkalemia, hyperuricemia and hypocalcemia are other common complications of rhabdomyolysis \[[@sfx121-B14]\]. The main step in management remains the early, aggressive repletion of fluids. Administration of sodium bicarbonate, which results in an alkaline urine, was first proposed by Bywaters and Beall, though studies did not show encouraging results \[[@sfx121-B15], [@sfx121-B16]\]. Long-term survival among patients with rhabdomyolysis and AKI is reported to be close to 80% \[[@sfx121-B17]\].

Hemolysis is the second most common cause of pigment nephropathy. Deposits of iron and hemosiderosis in the kidney have been observed in diseases with intravascular hemolysis, including PNH, valvular heart diseases and prosthetic heart valve implants, genetic hemoglobinopathies, malaria and transfusion of stored red blood cells \[[@sfx121-B18]\]. Mechanical trauma to erythrocytes liberates hemoglobin into plasma, which is bound by haptoglobin. This complex, taken up by the reticuloendothelial cells, is degraded. When plasma haptoglobin is fully saturated, free plasma hemoglobin dissociates to dimeric hemoglobin, which in turn dissociates into heme and globin \[[@sfx121-B22]\]. Heme proteins can cause AKI through decreased renal perfusion, direct cytotoxicity and intratubular casts formed from the interaction of heme proteins with Tamm--Horsfall protein. Episodes of AKI, especially those that fail to completely resolve, predispose to CKD \[[@sfx121-B23], [@sfx121-B24]\]. At mean follow-up, five (12%) patients had progressed to CKD. Out of these, two were due to severe rhabdomyolysis and three due to hemolysis.

AKI is a common but serious complication following cardiopulmonary bypass (CPB) and cardiac surgeries, and carries a poor prognosis. Hemodynamic/inflammatory factors and the release of labile iron, resulting in reactive oxygen species (ROS), are the major determinants of cardiac surgery-associated AKI \[[@sfx121-B25]\]. Biomarkers like neutrophil gelatinase-associated lipocalin (NGAL), liver-type fatty acid-binding protein and alpha-1 microglobulin predict the development of CPB-associated AKI, while hepcidin isoforms predict protection from AKI. NGAL participates in local iron transport while liver-type fatty acid-binding protein and alpha-1 microglobulin function as high-affinity heme-binding proteins and hepcidin in iron sequestration. Novel biomarkers point toward free iron-mediated (hemoglobin-induced) renal injury to be an important mechanism of AKI and to result in pigment nephropathy in these patients. Alkalinization of urine with sodium bicarbonate might protect from tubular cast formation from met-hemoglobin, proximal tubular cell necrosis by reduced endocytotic hemoglobin uptake and free iron-mediated ROS production and related injury \[[@sfx121-B26]\].

In a study of 14 patients of PNH by Ram *et al*., AKI was noted in six (42.8%) patients, five of whom had HD \[[@sfx121-B27]\]. Renal biopsy was done in four patients and all showed prominent hemosiderin pigments and acute tubular necrosis. At the end of 3 months after discharge, all patients had normal renal function.

Envenomation/poisonings, malaria, infections and sepsis often cause both rhabdomyolysis and hemolysis \[[@sfx121-B28]\]. There was no difference in the morphology of pigment casts or extent of tubular injury due to rhabdomyolysis or hemolysis in our study. We noted that Perls staining of cytoplasm with pigment cast points toward hemolysis as the etiology of AKI. In addition to clinical and laboratory evidence, immunohistochemistry of pigment casts will be helpful in clinching the etiology, though is not essential.

Snake envenomation is the most common cause of rhabdomyolysis and rifampicin is the most common cause of hemolysis causing pigment nephropathy in our study. It has a relatively good prognosis depending on the underlying etiology, though long-term follow-up is needed to ascertain the burden of pigment-induced nephropathy to CKD incidence in the future.
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